AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
209.27
+6.49 (3.20%)
May 12, 2026, 1:54 PM EDT - Market open
AbbVie Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 62,819 | 61,160 | 56,334 | 54,318 | 58,054 | 56,197 | |
Revenue Growth (YoY) | 9.50% | 8.57% | 3.71% | -6.44% | 3.30% | 22.69% |
Cost of Revenue | 18,420 | 18,204 | 16,904 | 20,415 | 17,414 | 17,446 |
Gross Profit | 44,399 | 42,956 | 39,430 | 33,903 | 40,640 | 38,751 |
Selling, General & Admin | 14,295 | 14,010 | 14,752 | 12,872 | 15,260 | 12,349 |
Research & Development | 9,501 | 9,096 | 12,791 | 7,675 | 6,510 | 6,922 |
Other Operating Expenses | 5,271 | 4,775 | 2,750 | 599 | 753 | 1,556 |
Total Operating Expenses | 29,067 | 27,881 | 30,293 | 21,146 | 22,523 | 20,827 |
Operating Income | 15,332 | 15,075 | 9,137 | 12,757 | 18,117 | 17,924 |
Interest Expense | -2,645 | -2,627 | -2,160 | -1,684 | -2,044 | -2,384 |
Other Non-Operating Income (Expense) | -6,712 | -5,851 | -3,261 | -4,823 | -2,596 | -2,551 |
Total Non-Operating Income (Expense) | -9,357 | -8,478 | -5,421 | -6,507 | -4,640 | -4,935 |
Pretax Income | 5,975 | 6,597 | 3,716 | 6,250 | 13,477 | 12,989 |
Provision for Income Taxes | 2,334 | 2,364 | -570 | 1,377 | 1,632 | 1,440 |
Net Income | 3,635 | 4,226 | 4,278 | 4,863 | 11,836 | 11,542 |
Minority Interest in Earnings | 6 | 7 | 8 | 10 | 9 | 7 |
Net Income to Common | 3,635 | 4,226 | 4,278 | 4,863 | 11,836 | 11,542 |
Net Income Growth | -13.35% | -1.22% | -12.03% | -58.91% | 2.55% | 150.04% |
Shares Outstanding (Basic) | 1,770 | 1,769 | 1,769 | 1,768 | 1,771 | 1,770 |
Shares Outstanding (Diluted) | 1,773 | 1,773 | 1,773 | 1,773 | 1,778 | 1,777 |
Shares Change (YoY) | 0.10% | - | - | -0.28% | 0.06% | 6.22% |
EPS (Basic) | 2.03 | 2.37 | 2.40 | 2.73 | 6.65 | 6.48 |
EPS (Diluted) | 2.03 | 2.36 | 2.39 | 2.72 | 6.63 | 6.45 |
EPS Growth | -13.62% | -1.26% | -12.13% | -58.97% | 2.79% | 137.13% |
Shares Outstanding | 1,767 | 1,768 | 1,765 | 1,766 | 1,769 | 1,768 |
Free Cash Flow | 19,980 | 17,816 | 17,832 | 22,062 | 24,248 | 21,990 |
Free Cash Flow Growth | 12.15% | -0.09% | -19.17% | -9.01% | 10.27% | 30.97% |
Free Cash Flow Per Share | 11.27 | 10.05 | 10.06 | 12.44 | 13.64 | 12.37 |
Dividends Per Share | 6.740 | 6.650 | 6.290 | 5.990 | 5.710 | 5.310 |
Dividend Growth | 1.35% | 5.72% | 5.01% | 4.90% | 7.53% | 9.71% |
Gross Margin | 70.68% | 70.24% | 69.99% | 62.42% | 70.00% | 68.96% |
Operating Margin | 24.41% | 24.65% | 16.22% | 23.49% | 31.21% | 31.89% |
Profit Margin | 5.80% | 6.92% | 7.61% | 8.97% | 20.40% | 20.55% |
FCF Margin | 31.81% | 29.13% | 31.65% | 40.62% | 41.77% | 39.13% |
EBITDA | 23,368 | 23,214 | 17,523 | 21,455 | 26,584 | 26,445 |
EBITDA Margin | 37.20% | 37.96% | 31.11% | 39.50% | 45.79% | 47.06% |
EBIT | 15,332 | 15,075 | 9,137 | 12,757 | 18,117 | 17,924 |
EBIT Margin | 24.41% | 24.65% | 16.22% | 23.49% | 31.21% | 31.89% |
Effective Tax Rate | 39.06% | 35.83% | -15.34% | 22.03% | 12.11% | 11.09% |
Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.